Ocugen partnered with Kwangdong to bring OCU400, a potential one-time gene therapy for RP blindness, to Korea. This could help 7,000 patients and brings Ocugen up to $7.5M upfront + royalties.
Hesai, a top Chinese LiDAR maker, won a $40M+ deal to supply US robotaxis as their sole LiDAR provider by 2026. This is Hesai's second US deal this month, reinforcing its global leadership in autonomous driving tech for L4 robotaxi fleets.
China found Nvidia violated anti-monopoly laws over its 2020 Mellanox acquisition, breaking conditional approval terms. Beijing continues its probe, raising tensions during ongoing US-China trade talks.
China launches anti-dumping and anti-discrimination investigations against US semiconductor companies, escalating trade tensions ahead of high-level talks.
Jamf, an Apple device management firm backed by Vista Equity, is exploring a sale due to weak stock performance and struggles with profitability, despite recent revenue growth. Vista is expected to sell its 34% stake.
IonQ's deal to buy Oxford Ionics got UK approval. This adds cool ion-trap tech to boost quantum computing, aiming for 2M qubits by 2030. Expect faster discoveries in medicine & more!
